Hartford Funds Management Co LLC

Position in LLY — ELI LILLY & Co

CIK 1546587 WAYNE, PA

Position in LLY

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$3,935,330

+$1,062,889 QoQ

Shares Held

3,281

+5.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

2.18%

of 13F equity value

Holder Rank

#1,900

of 4,605 holders

Holding Since

Mar 2022

18 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Hartford Funds Management Co LLC holds $9,254,965 across 5 Drug Manufacturers - General names. LLY ranks #1 (42.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	3,281	$3,935,330
2	GILD	Gilead Sciences, Inc.	18,436	$2,329,204
3	MRK	Merck & Co., Inc.	8,223	$1,056,655
4	AZN	Astrazeneca PLC	5,435	$1,030,584
5	PFE	Pfizer Inc	37,508	$903,192

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,935,330	3,281	+5.1%	Shares	Sole	2026-08-06
2026-03-31	$2,872,441	3,123	-2.8%	Shares	Sole	2026-05-04
2025-12-31	$3,454,021	3,214	+74.6%	Shares	Sole	2026-02-06
2025-09-30	$1,404,683	1,841	+2.1%	Shares	Sole	2025-11-13
2025-06-30	$1,406,272	1,804	+0.1%	Shares	Sole	2025-08-13
2025-03-31	$1,488,289	1,802	+23.3%	Shares	Sole	2025-05-06
2024-12-31	$1,128,664	1,462	+3.1%	Shares	Sole	2025-02-07
2024-09-30	$1,256,262	1,418	+4.0%	Shares	Sole	2024-11-12
2024-06-30	$1,234,032	1,363	+4.7%	Shares	Sole	2024-08-13
2024-03-31	$1,012,903	1,302	-12.7%	Shares	Sole	2024-05-06
2023-12-31	$869,716	1,492	-11.6%	Shares	Sole	2024-02-05
2023-09-30	$906,138	1,687	+5.8%	Shares	Sole	2023-11-03
2023-06-30	$748,023	1,595	-1.5%	Shares	Sole	2023-08-04
2023-03-31	$556,340	1,620	-0.2%	Shares	Sole	2023-04-28
2022-12-31	$594,124	1,624	+0.5%	Shares	Sole	2023-01-27
2022-09-30	$522,533	1,616	+35.2%	Shares	Sole	2022-11-07
2022-06-30	$387,454	1,195	+12.6%	Shares	Sole	2022-08-10
2022-03-31	$303,838	1,061	—	Shares	Sole	2022-05-09
No filing history on record for this holder in this stock.